Use of cyanobacterial gas vesicles as oxygen carriers in cell culture

A. Sundararajan,L. Ju

DOI: https://doi.org/10.1007/s10616-007-9044-9

2007-02-20

Abstract:

What problem does this paper attempt to address?

Protection Effects of Ulinastatin Against Lung Warm Ischemia-Reperfusion Injury in Rats

Feng MIAO,Gang CHEN,Zhi-ming CHEN,Lie-wen PANG,Qin-yun MA,Ji CHEN,Yong-jun ZHU

2010-01-01

Abstract:Objective To investigate the protective effect of ulinastatin against lung ischemia-reperfusion injury in rats and to compare the contribution of two different doses. Methods Thirty Sprague Dawley rats were randomly divided into three groups,with 10 rats in each.In ischemia-reperfusion group(IR group),the hilum of left lung was blocked for 1 hour and was then reopened.After 2 hours of reperfusion,blood sample from the left pulmonary vein was taken and the oxygen partial pressure was measured before the rats were sacrificed.The upper part of left lungs was assayed for wet/dry weight ratio(W/D),the middle part was taken for microscopic study,the other parts were frozen in liquid nitrogen for detection of myeloperoxidase concentration(MPO);In ulinastatin conventional dose group(UC group) and ulinastatin high-dose group(UH group),the rats were intravenously administered 10 000 IU/kg and 20 000 IU/kg ulinastatin,respectively,before blocking the hilum of the left lungs.The other procedures were the same as in the IR group. Results Compared IR group with the UH group,there was statistically significant difference in PO2 and W/D [(109.5±18.3)mmHg vs.(128.5±17.7)mmHg,5.30±0.13 vs.5.08±0.25,P0.05].For the results of MPO concentration,among IR group,UC group and UH group,there was statistically significant difference between each two groups [(57.36±10.51)ng/mL,(45.74±8.13)ng/mL and(28.30±6.28)ng/mL,P0.05].Tissue slice(HE stain) showed inflammatory cells infiltration in IR group. Conclusions The present study demonstrates that ulinastatin has a protective effect on rat lung warm ischemia-reperfusion injury,which was dose-dependent.
Early Protection by Resveratrol in Rat Lung Transplantation

Hai-Chao Xu,Wang Lv,Lu-Ming Wang,Peng Ye,Jian Hu

DOI: https://doi.org/10.12659/MSM.912345

2019-01-26

Abstract:BACKGROUND Resveratrol is a multifunctional bioactive substance that has effects in anti-inflammation and prevention of ischemia-reperfusion injury. This study compared the inflammation and expression of related proteins during the early stages after transplantation to explore the effects and mechanisms of resveratrol on transplanted lung. MATERIAL AND METHODS Sprague-Dawley rats were randomized to receive pretreatment of resveratrol suspension (60 mg/kg; RES group), dexamethasone (1 mg/kg; DEM group), or normal saline solution (2 mL/kg; control group) 1 h before lung transplantation. The cytokine concentration in the serum and bronchoalveolar lavage fluid (BALF) of the recipients was determined 24 h after transplantation. Histopathologic evaluation, including lung injury score, and the expression of necroptosis-associated proteins was assessed. RESULTS Histopathologic evaluation showed pneumocyte damage and endothelialitis associated with hemorrhage in the alveoli in the control group, the severity of which was greater than that in the other 2 groups. The levels of interleukin-6 and tumor necrosis factor-a in the serum and BALF of the RES and DEM groups were lower than those in the control group. The expression of necroptosis-associated proteins in the RES group was lower than that in the control group, and was inversely proportional to lung injury. CONCLUSIONS Pretreatment with resveratrol protected rat lung in the early stages after transplantation. We determined a relationship between necroptosis-associated proteins and transplanted lung injury, which suggests that the mechanism of lung transplantation-associated ischemia-reperfusion injury may be related to necroptosis.
The Effect of "Proanthocyanidin" on Ischemia-Reperfusion Injury in Skeletal Muscles of Rats

Abdullah Özer,Başak Koçak,Şaban Cem Sezen,Mustafa Arslan,Mustafa Kavutçu

DOI: https://doi.org/10.3390/medicina60050804

2024-05-13

Abstract:Background and Objectives: Lower limb skeletal muscle ischemia-reperfusion (IR) injury is associated with increased morbidity and mortality, and it is common in several clinical situations such as aortic aneurysms repairment, peripheral arterial surgery, vascular injury repairment, and shock. Although it is generally accepted that oxidative stress mediators have a significant role in IR injury, its precise mechanism is still unknown. Anecdotally, it is sustained not only by structural and functional changes in the organ it affects but also by damage to distant organs. The purpose of this report is to illustrate the effect of proanthocyanidin on IR injury. Materials and Methods: In our study, 18 male Wistar albino rats were used. The subjects were divided into three groups containing six mice each (control, C; ischemia-reperfusion, IR; ischemia-reperfusion and proanthocyanidin; IR-PRO). Intraperitoneal proanthocyanidin was given to the IR and proanthocyanidin groups 30 min before laparotomy, and 1 h ischemia led to these two groups. After one hour, reperfusion started. Muscle atrophy-hypertrophy, muscle degeneration-congestion, fragmentation-hyalinization, muscle oval-central nucleus ratio, leukocyte cell infiltration, catalase enzyme activity, and TBARS were all examined in lower-limb muscle samples after one hour of reperfusion. Results: When skeletal muscle samples were evaluated histopathologically, it was discovered that muscle atrophy-hypertrophy, muscle degeneration-congestion, fragmentation-hyalinization, and leukocyte cell infiltration with oval-central nucleus standardization were significantly higher in the IR group than in the C and IR-P groups. Oval-central nucleus standardization was significantly higher in the IR and IR-PRO groups than in the control group. TBARS levels were significantly higher in the IR group than in the control and IR-PRO groups, while catalase enzyme activity was found to be significantly lower in the IR group than in the control and IR-PRO groups. Conclusions: As a consequence of our research, we discovered that proanthocyanidins administered before IR have a protective impact on skeletal muscle in rats. Further research in this area is required.
Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation

G Thabut,O Brugière,G Lesèche,J B Stern,K Fradj,P Hervé,G Jebrak,J Marty,M Fournier,H Mal

DOI: https://doi.org/10.1097/00007890-200105150-00019

2001-05-15

Transplantation

Abstract:Background: The preventive effect of inhaled nitric oxide (NO) and pentoxifylline (PTX) administered during reperfusion has been demonstrated on experimental models of lung ischemia/reperfusion (I/R) injury but this strategy is not validated in clinical lung transplantation. The aim of this study was to assess retrospectively the protective effect of inhaled NO and PTX after lung transplantation. Methods: Twenty-three consecutive patients who received inhaled NO (10 ppm) and PTX (NO-PTX group) at the time of reperfusion were compared retrospectively with (1) 23 consecutive patients transplanted just before the use of NO-PTX (control group 23); (2) 95 patients representing all the patients of the series who did not receive NO-PTX (control group 95), with respect to I/R injury related complications. In particular, the incidence of pulmonary reimplantation edema and early hemodynamic failure, the PaO2/FIO2 ratio as well as the duration of mechanical ventilation and the 2-month mortality rates were compared. Results: Reimplantation edema was observed in 6/23 patients (26%) in the NO-PTX group vs. 13/23 patients (56%) in the control group 23 (P=0.035) and 48/95 patients (50%) in the control group 95 (P=0.035). The worst PaO2/FIO2 ratio during the first three postoperative days was 240-102 mmHg in the NO-PTX group vs. 162+/-88 mmHg (P=0.01) and 176+/-107 mmHg (P=0.01) in the control group 23 and the control group 95, respectively. The duration of mechanical ventilation was 2.1+/-2.4 days in the NO-PTX group vs. 7+/-9 days in the control group 23 (P=0.02) and 6+/-7 days in the control group 95 (P=0.01). The 2-month mortality rate was 4.3% in the NO-PTX group vs. 26% (P=0.04) and 21% (P=0.07) in the control group 23 and the control group 95, respectively. Conclusions: The marked decrease in the incidence of allograft dysfunction compared with two historical control groups suggests that PTX and inhaled NO given before and throughout reperfusion are protective against I/R injury in the setting of clinical transplantation.
Process control using VSI cause selecting control charts

Su-Fen Yang

DOI: https://doi.org/10.1007/s10845-009-0261-2

IF: 8.3

2010-12-01

Journal of Intelligent Manufacturing

Abstract:
Preventive Effects Of Curcumin And Dexamethasone On Lung Transplantation-Associated Lung Injury In Rats

Jiayuan Sun,Weigang Guo,Yong Ben,Jinjun Jiang,Changjun Tan,Zude Xu,Xiangdong Wang,Chunxue Bai

DOI: https://doi.org/10.1097/CCM.0b013e31816a06fc

IF: 8.8

2008-01-01

Critical Care Medicine

Abstract:Objective: To investigate potential effects of curcumin or dexamethasone on lung transplantation-associated lung injury.Design: Prospective, randomized, controlled study.Setting: Research laboratory.Subjects: Adult male Sprague-Dawley rats.Interventions: Sham-operated rats were used as time-matched controls. Experimental rats were subjected to unilateral orthotopic lung transplantation with 4 hrs of cold ischemia followed by 2 hrs (or 24 hrs) of reperfusion. Animals were randomly assigned to vehicle-, curcumin-, or dexamethasone-treated groups.Measurements and Main Results: Transplantation-associated lung injury was characterized by an increased alveolar-capillary permeability and myeloperoxidase activity and decreased levels of arterial oxygen tension/inspired oxygen concentration ratio. Pretreatment with curcumin and dexamethasone significantly prevented barrier disruption, lung edema, tissue inflammation, and decreased PaO2 at the early stage of posttransplantation. Nuclear factor-kappa B in transplanted lungs was activated, accompanied by an increase in messenger RNA levels and protein content of tumor necrosis factor-alpha, interleukin-6, and matrix metalloproteinase-9 in lung graft. Those changes were prevented by pretreatment with curcumin and dexamethasone.Conclusions. Curcumin can be an alternative therapy for protecting lung transplantation-associated injury by suppressing nuclear factor-kappa B- mediated expression of inflammatory genes.
Sweet and Minty: A 2 Year Old With a Fatal Household Ingestion

V. R. Maharaj,J. Paul,Y. Finkelstein

DOI: https://doi.org/10.1097/PEC.0000000000000980

2016-12-01

Pediatric Emergency Care

Abstract:Points to consider: 1. This is a 2-year-old with ingestion of unknown substance with a minty smell. Initially tachycardic, he had 2 generalized seizures, became more tachycardic and tachypneic with bilateral crepitations, required intubation and had a cardiac arrest. A2-year-old, 12.6 kg, previously healthy male was referred to the pediatric ED in Trinidad from a community emergency department (ED) after ingestion of an unknown substance resulting in 5 episodes of vomiting as well as tremor. The ingestion was unwitnessed, but his parents detected a minty smell from his mouth, skin, and clothes. On presentation at the community ED, approximately 2 hours after ingestion, his vital signs were: blood pressure, 100/70mmHg; pulse, 149/min; respiratory rate, 32 breaths per minute; temperature, 36.4°C; SpO2, 100% in room air and Glasgow Coma Scale 15. He was administered 12 g (1 g/kg) of activated charcoal orally, an intravenous access was established and a bolus of 250 mL (20 mL/kg) of normal saline was infused. On arrival to the pediatric ED 5 hours post-ingestion, he appears alert and active with Glasgow Coma Scale 15. His vital signs indicate that he is afebrile (36.3°C), tachycardic (154 bpm), and tachypneic (48 breaths per minute). His SpO2 is measured by pulse oximetry to be 100% in room air, his blood pressure is 106/86 mm Hg, his capillary refill time is 1 second, and blood glucose is 136 mg/dL (7.5 mmol/dL). On examination, his airway is patent; lungs are clear bilaterally; there are normal pulses, normal heart sounds, and no murmurs.
Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells.

Yasuhisa Tango,T. Fujiwara,T. Itoshima,Yoshiko Takata,K. Katsuda,F. Uno,S. Ohtani,T. Tani,J. Roth,N. Tanaka

DOI: https://doi.org/10.1089/104303402760128595

2002-07-20

Human Gene Therapy

Abstract:p14(ARF), a product of the INK4A/ARF locus, induces p53 upregulation by neutralizing the effects of MDM2, a transcriptional target of p53 that antagonizes its function. Here we report that adenovirus-mediated p14(ARF) gene transfer leads to the accumulation of ectopically transduced p53 and to apoptosis in human cancer cells. We constructed an adenoviral vector expressing p14(ARF) (Ad-ARF) and examined its synergistic effect with p53-expressing adenovirus (Ad5CMV-p53 or Ad-p53) in human lung and esophageal cancer cells. Simultaneous Ad-ARF and Ad-p53 infection increased p53 protein levels not only in a wild-type p53-expressing cell line, but also in cell lines with deleted p53. This resulted in a significant in vitro cytotoxicity compared with Ad-p53 infection alone. Coinfection of Ad-ARF and Ad-p53 also resulted in an increase in expression of p53-inducible genes, including p21(WAF-1/Cip1), p53R2, and Noxa. In addition, the growth of human lung cancer tumors subcutaneously implanted into nu/nu mice was inhibited significantly by intratumoral injection with Ad-ARF and Ad-p53. Our data demonstrate that overexpression of ectopic p14(ARF) may render cells more sensitive to p53-mediated apoptosis, an outcome that has important implications for the treatment of human cancers.
Protective Effects of Ulinastatin on Ischemia-Reperfusion Iiyury During Rat Non-Heart Beating Donor Lung Transplantation

WANG Ye-ming,CHEN Jing-yu,TONG Ji-chun,WANG Yong

DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2013.08.014

2013-01-01

Abstract:Objective To investigate the protective effects of ulinastatin (UTI) on ischemiareperfusion injury of donor lungs,and the possible mechanism.Method Forty male SD rats were randomly divided into two groups:group C as control group and group U as UTI group.In group C donor lungs were antegradely flushed with 20 ml of cold (4 C) low potassium dextron (LPD) solution and 5 ml retrogradely.Meanwhile,in group U,UTI (500 000 U/L) was added in LPD solution and the same doses were used.According to the time after initiation of reperfusion,each group was divided into two subgroups:30 min (subgroup A) and 1 h (subgroup B).Arterial blood samples were collected for blood gas analysis.Lung samples were obtained at the end of reperfusion (30 min or 1 h).Microscopic examination of the donor lungs was conducted.Besides,the pulmonary water index (W/D),tissue malondialdehyde (MDA) and superoxide dismutase (SOD) content,and mRNA expression of tumor necrosis factor (TNF-a),intercellular adhesion molecule 1 (ICAM-1) and interleukin 10 (IL-10) were also measured.Results (1) One h after reperfusion,oxygenation index in group U was higher than that in group C (P =0.025) ; (2) The levels of W/D in subgroup A and subgroup B of group U were decreased as compared with group C (P =0.005 and P =0.006) ; (3)The microscopic changes of donor lung tissues in group U were lessen than in group C; (4) In subgroup A of group U,MDA content was decreased (P=0.039),and SOD content was increased (P=0.035),and similar results could be observed in subgroup B of group U (P =0.006 and P =0.030 respectively); (5) As compared with group C,the mRNA expression of TNF-α in group U was decreased at the time of 30 min after reperfusion (P =0.000),but no significant change was found at the time of 1 h (P =0.139).The mRNA expression of ICAM-1 was not decreased evidently at the time of 30 min (P=0.062),but significantly decreased at the time of 1 h (P=0.001).The mRNA expression of IL-10 was increased in subgroups A and B (P =0.004 and P =0.000 respectively).Conclusion This study demonstrated that UTI had protective effects of reducing ischemia-reperfusion injury on the donor lungs after lung transplantation in rat non-heart beating donor models.
Intravenous aprotinin attenuates lung ischemia-reperfusion injury in a rat lung transplantation model

杨帆,姜冠潮,黄宇清,赵辉,刘军

DOI: https://doi.org/10.3321/j.issn:1001-9030.2008.09.012

2008-01-01

Abstract:Objective To evaluate the effect of intravenous aprotinin application on ischemiareperfusion iniury after lung trailsplantation.Methods An isehemia-reperfusion model after lung transplantation in rats was established and received intravenous aprotinin.Cytokine levels and myeloperoxidase activity were measured in order to explore the mechanism.Rtsults Intravenous aprotinin attenuated ischemia-reperfusion injury estimated by blood gas and wet/dry ratio.The levels of IL-2 in bronchoalveolar lavage[(113±32)μg/L vs(162±43)μg/L,P＜0.05],serum levels of IL-8[(7.26±1.01)ng/Lvs(9.43±0.97)ng/L,P＜0.05]and TNF-α[(152.3±36.4)ng/L vs(211.6±52.7)ns/L,P＜0.05],and lung tissue myelopcroxidase activity[(2.36±0.62)U/g vs(3.98±0.36)U/g,P＜0.05]were significantly reduced in the aprotinin group.Conclusion Apmtinin attenuates lung ischemia-reperfusion iniury after lung transplantation by lessen the release of IL-2,inhibiting the activation of TNF-α and production of IL-8.and suppressing the accumulation,activation and deganulation of neutrophils.
Effect of aprotinin on improving graft function and inhibiting apoptosis of pulmonary cells of lung inplant after lung transplantation

Chen Xingpeng,Wu Qingyu,Pan Guangyu

DOI: https://doi.org/10.3321/j.issn:0577-7402.2007.02.016

2007-01-01

Medical Journal of Chinese People's Liberation Army

Abstract:Objective To study the effect of aprotinin on improving graft function and inhibiting cell apoptosis of cells of donor lung after transplantation and to in vestigate the relation between post-transplant lung function and apoptosis.Methods On an isolated,whole blood-perfused,ventilated rabbit lung transplantation model,24 rabbits were divided into two groups:in group A the donor lung block was flushed with LPD solution through the pulmonary artery,and in group B aprotinin in 150KIU/ml was added to the pulmonary flushing fluid.Oxygenation capacity(PaO2,PaCO2)and pulmonary compliance(PaP,PawP,CL)were continuously monitored during the one-hour cyclic perfusion.The structural and ultrastructural changes in the donor lung were examined before and after transplantation.Terminal deoxynucleotidyl transferase-uridine nucleotide end-labeling(TUNEL-Fluorescein)and propidium iodide(PI)double staining techniques were used to detect apoptosis of donor lung before and after transplantation.Results The donor lung in group B had significantly better oxygenation capacity during 60 minutes of reperfusion(PaO2>112.33mmHg).PaO2 of group B was significantly higher than those of group A after 30 minutes of reperfusion(54.42-118.87mmHg vs 112.33-183.73mmHg,P<0.01).PaCO2 in group A was significantly higher than that in group B(50.96mmHg vs 41.42mmHg,P<0.01).PaP and PawP in group A were higher than that in group B after 20min and 30min of reperfusion(P<0.001).CL of group B was higher than that of group A(0.156 vs 0.120cm3·cmH2O-1,P<0.01).Electron microscopy revealed that ultrastructure of donor lung in group B was well preserved after 60min of reperfusion.TUNEL-Fluorescein and PI double staining revealed that almost no evidence of apoptosis was found in specimens after cold ischemic periods.Significant increase in the numbers of cells undergoing apoptosis were observed after graft reperfusion.And there were significantly more apoptotic cells in groups A(24.67%)compared with groups B(15.50%)after transplantation(P<0.01).The percentage of apoptosis cells were inversely correlated with post-transplant donor lung function(r=-0.895,P<0.001).Conclusion The addition of aprotinin to LPD solution may improve donor lung function by inhibiting apoptosis in the early reperfusion period.The apoptosis might contribute to ischemia-reperfusion injury during the early phase of graft reperfusion and be responsible for severe organ dysfunction.
Comparation of the Effects of Ulinastatin and N-desulfated Heparin on Ischemia-reperfusion Injury after Lung Transplantation in Rats

郭卫刚,谭黎杰,刘愉,王群,赵德平,薛亮,葛棣

DOI: https://doi.org/10.3969/j.issn.1008-6358.2005.06.005

2005-01-01

Abstract:Objective: To build an orthotopic single left lung allograft animal model in rats and compare the effects of ulinastatin (UTI) and non-anticoagulant N-desulfated heparin (NNH) on lung ischemia-reperfusion injury after lung transplantation. Methods: 24 Male SD rats weighted 250-350g were randomly divided into 3 groups. At the time of reperfusion, the control group were given saline 1. 2ml/kg (n = 8); the UTI group were given UTI 10,000 U/kg (n=8); the NNH group were given NNH 12mg/kg , we completed 24 rat left lung transplantation assisted by mechanical ventilation and microscopy. 2 hours after reperfusion, the transplanted lung's pulmonary vein blood gases, wet dry ratio(W/D) and myeloperoxidase(MPO) were measured. Tumor necrosis factor-α(TNF-α) and interleukin 8(IL-8) were measured by method of ELISA. Intercilluar adhesion molecule-1( IC AM-1) mRNA in lung tissue were measured by method of RT-PCR, pathology slice were done routinely. Results: Among 24 transplanted rats, 21 survived at the end point, the transplantation success rate was 87. 5% and the procedure success rate was 100%. Among the 3 failure cases, 2 died in 75 minutes and 90 minutes after reperfusion respectively. Another one was still alive, however, thrombus was found in the pulmonary artery and vein at autopsy, thus the transplanted lung was not perfused. PaO2 in the UTI group(289. 68±5. 65mmHg) and the NNH group(315. 26 ± 14. 91mmHg) was significantly higher (P0.0001) than the control group (236. 80 ±13. 90mmHg ), and the NNH group was singnificantly higher than the UTI group(P 0.0001). W/D ratio has no difference(P=0.18) within the UTI group(4.74 ±0. 28) ,the NNH group (4. 87 ±0. 34) and the control group (5. 00 ± 0. 12), MPO activity in the UTI group(0. 52 ± 0. 25) was lower than the control group(0. 84±0. 22, P0.05), and the difference within the NNH group(0. 64 ± 0. 24), the control group and the UTI group was not apparent(P=0. 12, P=0. 29). In the lung tissue, the concentrations of TNF-a in the UTI group (138. 61 ± 15. 30) were significantly higher than the control group(77. 54 ± 10.14, P0. 0001), the NNH group(52. 85 ± 6. 55) was significantly lower than the control group(P0.0001). In the lung tissue, the concentrations of IL-8 in UTI group(173. 45± 27. 63) were significantly higher than the control group(76. 22 ?12. 42, P0.0001) and the NNH group(61. 34 ± 9. 86,P0. 0001), and there was no difference between the control group and the NNH group(P=0. 12). ICAM-1 mRNA in the UTI group(0. 37 ± 0. 14) and the NNH group(0. 38 ± 0. 11 )5. 00 ± 0. 12, P0. 01 and P0. 0001) were significantly lower than the control group(1. 74 ±0. 39,P0. 0001), and there was no difference between the UTI group and the NNH group(P=0. 94). Histological appearances showed less lung tissue damage in the UTI and NNH group. Conclusion: Rat left lung transplantation model with non-vessel endo-thelium cuff technique is easy to do and acceptable for short period research. UTI and NNH both prevented lung reperfusion injury after lung transplantation in rats. UTI can significantly reduce oxygen derived free radicals. NNH depressed the expression of proinflammatory fator and improved the function of transplanted lung, and have more significantly effect on preventing the lung reperfusion injury after lung transplantation in rats.
C1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog

A Salvatierra,F Velasco,M Rodriguez,A Alvarez,R Lopez-Pedrera,R Ramirez,J Carracedo,F Lopez-Rubio,J Lopez-Pujol,R Guerrero

DOI: https://doi.org/10.1164/ajrccm.155.3.9117001

Abstract:The success of lung transplantation to a large extent depends on effective protection of the graft from ischemic injury after reperfusion. Although mechanisms have not been clarified, the pathologic findings of ischemic injury after reperfusion are similar to adult respiratory distress syndrome, a condition in which the blood coagulation contact system is activated. This study evaluates the effect of C1-esterase inhibitor (C1-INH), the main inhibitor of the blood coagulation contact system, on short-term lung function in a dog model of orthotopic lung transplantation. Twelve lung transplantations were performed after 24 h of ischemic time. Dogs were randomly assigned to receive either vehicle (Control) or C1-INH. After the lung transplantation in the control group, Pao2 decreased by 84% and both the AaPO2 and the Qs/Qt% increased (340 and 530%, respectively, p < 0.01); these parameters remained unchanged in the C1-INH group. The hypoxemia observed in control animals was associated with decreased blood coagulation contact factors, complement consumption, increased expression of adhesion glycoproteins in leukocytes, and extensive intraalveolar and interstitial neutrophil infiltration. In contrast, C1-INH administration prevented hypoxemia, the decrease in blood coagulation contact factors, the activation of the complement system, the increase in expression of leukocyte adhesion molecules, and inflammatory cell infiltrate. This study has demonstrated that in a dog model of lung transplantation, the administration of C1-INH prevents early pulmonary dysfunction, and it suggests that activation of blood coagulation contact system and complement are important mechanisms causing ischemic injury after reperfusion.
Effects of Warm Versus Cold Ischemic Donor Lung Preservation on the Underlying Mechanisms of Injuries During Ischemia and Reperfusion

Ilker Iskender,Marcelo Cypel,Tereza Martinu,Manyin Chen,Jin Sakamoto,Hyunhee Kim,Keke Yu,Huiqing Lin,Zehong Guan,Kohei Hashimoto,Thomas K Waddell,Mingyao Liu,Shaf Keshavjee

DOI: https://doi.org/10.1097/TP.0000000000002140

Transplantation

Abstract:Background: Ischemia-reperfusion injury related to lung transplantation is a major contributor to early postoperative morbidity and mortality. We hypothesized that donation after cardiac death donor lungs experience warm ischemic conditions that activate different injurious mechanisms compared with donor lungs that undergo prolonged cold ischemic conditions. Methods: Rat donor lungs were preserved under different cold ischemic times (CIT) (12 hours or 18 hours), or under warm ischemia time (WIT) (3 hours) after cardiac death, followed by single left lung transplantation. Lung function was analyzed during the 2-hour reperfusion period. Microscopic injury, cell death, energy status, and inflammatory responses were assessed. Results: Pulmonary oxygenation function was significantly worse in both 18hCIT and WIT groups, accompanied by higher peak airway pressure, acute lung injury scores, and expression of cell death markers compared with the 12hCIT control group. In lung tissue, reperfusion induced increased expression levels of interleukin (IL)-1α, IL-1β, IL-6, and chemokines CCL2, CCL3, CXCL1, and CXCL2 in CIT lungs. Notably, these changes were much lower in the WIT group. Additionally, plasma levels of IL-6, IL-18, CCL2, and vascular endothelial growth factor were significantly higher, and adenosine triphosphate levels were significantly reduced in warm versus cold ischemic lungs. Conclusions: Compared with 12hCIT, posttransplant pathophysiology deteriorated similarly in both 18hCIT and WIT groups. However, tissue adenosine triphosphate levels and inflammatory profiling differed between warm versus cold ischemic donor lungs. These differences should be carefully considered when developing specific therapeutic strategies to reduce ischemia-reperfusion injury in lung transplantation.
Extracorporeal cytokine adsorption reduces systemic cytokine storm and improves graft function in lung transplantation

Jonas Peter Ehrsam,Stephan Arni,Miriam Weisskopf,Miriam Nowack,Ilhan Inci

DOI: https://doi.org/10.1016/j.xjon.2023.06.011

2023-07-04

JTCVS Open

Abstract:Objectives: Ischemia-reperfusion injury often coincides with a cytokine storm, which can result in primary graft dysfunction following lung transplantation. Our previous research has demonstrated allograft improvement by cytokine adsorption during ex vivo lung perfusion. The aim of this study was to investigate the effect of in vivo extracorporeal cytokine adsorption in a large animal model. Materials and methods: Pig left lung transplantation was performed following 24 hours of cold ischemic storage. Observation period after transplantation was 24 hours. In the treatment group (n = 6), extracorporeal CytoSorb adsorption was started 30 minutes before reperfusion and continued for 6 hours. A control group (n = 3) did not receive adsorber treatment. Results: During adsorption, we consistently noticed a significant decrease in plasma proinflammatory interleukin (IL)-2, trends of less proinflammatory, tumor necrosis factor- α, IL-1α, and granulocyte-macrophage colony-stimulating factor as well as significantly reduced systemic neutrophils. In addition, a significantly lower peak airway pressure was detected during the 6 hours of adsorption. After 24 hours of observation, when evaluating the left lung allograft independently, we observed significantly improved CO2 removal, partial pressure of oxygen/inspired oxygen fraction ratio, and less acidosis in the treatment group. At autopsy, bronchoalveolar lavage results exhibited significantly lower recruitment of cells and less pro-inflammatory IL-1α, IL-1β, IL-6, and IL-8 in the treatment group. Histologically, the treatment group had a strong trend, indicating less neutrophil invasion into the alveolar space. Conclusions: Based on our findings, cytokine adsorption during and after reperfusion is a viable approach to reducing posttransplant inflammation following lung transplantation. CytoSorb may increase the acceptance of extended criteria donor lungs, which are more susceptible to ischemia-reperfusion injury.
Cell death and ischemia-reperfusion injury in lung transplantation

Megan Capuzzimati,Olivia Hough,Mingyao Liu

DOI: https://doi.org/10.1016/j.healun.2022.05.013

Abstract:Lung transplantation is the most effective therapy for patients with end-stage lung disease. However, concern of donor lung damage and ischemia-reperfusion induced lung injury limits the use of "marginal" donor lungs. Recent transcriptomic studies have demonstrated that the enrichment of gene-clusters related to cell death and inflammation are the most profound signals during ischemia-reperfusion in human lung transplants. Herein, we focus on the relationship between inflammation and programmed cell death, especially necroptosis, mitochondrial permeability transition-initiated regulated necrosis, pyroptosis, ferroptosis, and autophagic cell death. Cell death-related molecules have been tested as potential biomarkers for donor lung assessment. Inhibitors for various types of cell death have been explored as therapeutics for ischemia reperfusion injury in lung transplantation. A deeper understanding of these mechanisms may help to improve donor management, organ preservation, prevention and treatment of primary graft dysfunction during and post transplantation. Moreover, evaluation and treatment of cell death and inflammation during ex vivo lung perfusion may be a game changer in donor organ management, assessment, repair, and reconditioning.
Evaluation of the effects of ischemia-reperfusion injury in rat isogenic and allogeneic muscle and skin transplant models

Fatih Ceran,Salih Onur Basat,İdris Ersin,Deniz Filinte,Özgür Pilancı,Mehmet Bozkurt

DOI: https://doi.org/10.14744/tjtes.2024.77415

Abstract:Background: Ischemia-reperfusion injury (IRI) is a phenomenon that affects transplant survival. The aim of our study was to examine the effects of IRI in isogenic and allogeneic muscle and skin transplantation models exposed to prolonged warm ischemia. Methods: Forty-eight Lewis rats and 16 Brown-Norway rats were used to create four groups: Isogenic Inguinal Flap Transplantation (IST), Isogenic Gastrocnemius Muscle Flap Transplantation (IMT), Allogeneic Inguinal Flap Transplantation (AST), and Allogeneic Gastrocnemius Muscle Flap Transplantation (AMT). Malonyldialdehyde (MDA) and superoxide dismutase (SOD) levels were measured on postoperative days 1, 7, 21, 35, 63, 100, and 120 in all groups. Donor-specific chimerism (DSC) in peripheral blood was evaluated in the allogeneic groups on postoperative days 7, 21, 35, 63, 100, and 120. The microRNA-21 and microRNA-205 levels were evaluated on postoperative days 1, 7, and 120 in all groups. At the end of the study, a histopathological examination was performed. Results: A statistically significant difference was found between the groups in terms of MDA and SOD levels. DSC was detected in the AMT group. A significant increase in microRNA-205 was observed, especially in the AMT group. There was no significant difference in the number of functional muscle units between the muscle transplantation groups. Conclusion: The presence of DSC in the AMT group and the lack of a significant difference in the number of functional muscle units in the IMT and AMT groups are noteworthy findings.
Altered purine metabolism at reperfusion affects clinical outcome in lung transplantation

Cristina Baciu,Jason Shin,Michael Hsin,Marcelo Cypel,Shaf Keshavjee,Mingyao Liu

DOI: https://doi.org/10.1136/thoraxjnl-2021-217498

Thorax

Abstract:Introduction: Lung transplantation is an established treatment for patients with end-stage lung disease. However, ischaemia reperfusion injury remains a barrier to achieving better survival outcomes. Here, we aim to investigate the metabolomic and transcriptomic profiles in human lungs before and after reperfusion, to identify mechanisms relevant to clinical outcome. Methods: We analysed 67 paired human lung tissue samples collected from 2008 to 2011, at the end of cold preservation and 2 hours after reperfusion. Gene expression analysis was performed with R. Pathway analysis was conducted with Ingenuity Pathway Analysis. MetaboAnalyst and OmicsNet were used for metabolomics analysis and omics data integration, respectively. Association of identified metabolites with transplant outcome was investigated with Kaplan-Meier estimate and Cox proportional hazard models. Results: Activation of energy metabolism and reduced antioxidative biochemicals were found by metabolomics. Upregulation of genes related to cytokines and inflammatory mediators, together with major signalling pathways were revealed by transcriptomics. Purine metabolism was identified as the most significantly enriched pathway at reperfusion, based on integrative analysis of the two omics data sets. Elevated expression of purine nucleoside phosphorylase (PNP) could be attributed to activation of multiple transcriptional pathways. PNP catabolised reactions were evidenced by changes in related metabolites, especially decreased levels of inosine and increased levels of uric acid. Multivariable analyses showed significant association of inosine and uric acid levels with intensive care unit length of stay and ventilation time. Conclusion: Oxidative stress, especially through purine metabolism pathway, is a major metabolic event during reperfusion and may contribute to the ischaemia reperfusion injury of lung grafts.
Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia

Wei Zhai,Markus Cardell,Ingrid De Meester,Koen Augustyns,Sven Hillinger,Ilhan Inci,Stephan Arni,Wolfgang Jungraithmayr,Simon Scharpé,Walter Weder,Stephan Korom

DOI: https://doi.org/10.1016/j.healun.2006.11.601

Abstract:Background: CD26/DPP IV is a T-cell-membrane protein that cleaves dipeptides from extracellular peptides. Inhibition of its enzymatic activity using Pro-Pro-diphenylphosphonate derivatives has been shown to abrogate acute and accelerated rejection in models of cardiac and pulmonary allotransplantation. Here we investigated the effects of enzymatic DPP IV inhibition on ischemia/reperfusion (I/R) injury after extended ischemia before pulmonary transplantation. Methods: A syngeneic rat orthotopic left-lung transplantation model was used. Group I donor lungs (controls) were flushed and preserved in Perfadex for 18 hours at 4 degrees C and then transplanted and reperfused for 2 hours. Group II grafts were perfused with and stored in Perfadex + 25 micromol/liter AB192 [bis(4-acetamidophenyl) 1-(S)-prolylpyrrolidine-2(R,S)-phosphonate]. Group III lungs were perfused with Perfadex + AB192, and stored in Perfadex. After 2-hour reperfusion, oxygenation, peak airway pressure (PawP), graft wet/dry (W/D) weight ratio, myeloperoxidase activity, thiobarbituric acid-reactive substances, graft specific DPP IV enzymatic activities and histomorphology were analyzed. Results: AB192 perfusion significantly reduced DPP IV intragraft enzymatic activity in Groups II and III. Compared with controls, transplants from Groups II and III showed significantly improved oxygenation capacity, PawP and W/D weight ratio, with lower intragraft lipid peroxidation; and preserved histologic structure. Conclusions: Targeting intragraft DPP IV enzymatic activity attenuated post-transplantation I/R injury and preserved early graft function after extended ischemia.
Protective Effect of L-Arginine Preconditioning on Ischemia and Reperfusion Injury Associated with Rat Small Bowel Transplantation

Bin Cao,Ning Li,Yong Wang,Jie-Shou Li

DOI: https://doi.org/10.3748/wjg.v11.i19.2994

IF: 5.374

2005-01-01

World Journal of Gastroenterology

Abstract:AIM:To investigate the protective effect and possible mechanism of L-arginine preconditioning on ischemia and reperfusion injury associated with small bowel transplantation (SBT).METHODS:Male inbred Wistar rats weighting between 180 and 250 g were used as donors and recipients in the study. Heterotopic rat SBT was performed according to the techniques of Li and Wu. During the experiment, intestinal grafts were preserved in 4 degrees Ringer's solution for 8 h before being transplanted. Animals were divided into three groups. In group 1, donors received intravenous L-arginine (50 mg/kg, 1 mL) injection 90 min before graft harvesting. However, donors in control group were given normal saline (NS) instead. In group 3, six rats were used as sham-operated control. Specimens were taken from intestinal grafts 15 min after reperfusion. Histological grading, tissue malondialdehyde (MDA) and myeloperoxidase (MPO) levels were assessed. The graft survival of each group was monitored daily until 14 d after transplantation.RESULTS:Levels of MDA and MPO in intestine of sham-operated rats were 2.0+/-0.22 mmol/g and 0.66+/-0.105 U/g. Eight hours of cold preservation followed by 15 min of reperfusion resulted in significant increases in tissue MDA and MPO levels. Pretreatment with L-arginine before graft harvesting resulted in lower enhancement of tissue levels of MDA and MPO and the differences were significant (4.71+/-1.02 mmol/g vs 8.02+/-3.49 mmol/g, 1.03+/-0.095 U/g vs 1.53+/-0.068 U/g, P<0.05). Besides, animals in L-arginine pretreated group had better histological structures and higher 2-wk graft survival rates comparing with that in NS treated group (3.3+/-0.52 vs 6+/-0.1, 0/6 vs 6/6, P<0.05 or 0.01).CONCLUSION:L-arginine preconditioning attenuates ischemia and reperfusion injury in the rat SBT model, which was due to antioxidant activities partially.

Use of cyanobacterial gas vesicles as oxygen carriers in cell culture

Protection Effects of Ulinastatin Against Lung Warm Ischemia-Reperfusion Injury in Rats

Early Protection by Resveratrol in Rat Lung Transplantation

The Effect of "Proanthocyanidin" on Ischemia-Reperfusion Injury in Skeletal Muscles of Rats

Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation

Process control using VSI cause selecting control charts

Preventive Effects Of Curcumin And Dexamethasone On Lung Transplantation-Associated Lung Injury In Rats

Sweet and Minty: A 2 Year Old With a Fatal Household Ingestion

Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells.

Protective Effects of Ulinastatin on Ischemia-Reperfusion Iiyury During Rat Non-Heart Beating Donor Lung Transplantation

Intravenous aprotinin attenuates lung ischemia-reperfusion injury in a rat lung transplantation model

Effect of aprotinin on improving graft function and inhibiting apoptosis of pulmonary cells of lung inplant after lung transplantation

Comparation of the Effects of Ulinastatin and N-desulfated Heparin on Ischemia-reperfusion Injury after Lung Transplantation in Rats

C1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog

Effects of Warm Versus Cold Ischemic Donor Lung Preservation on the Underlying Mechanisms of Injuries During Ischemia and Reperfusion

Extracorporeal cytokine adsorption reduces systemic cytokine storm and improves graft function in lung transplantation

Cell death and ischemia-reperfusion injury in lung transplantation

Evaluation of the effects of ischemia-reperfusion injury in rat isogenic and allogeneic muscle and skin transplant models

Altered purine metabolism at reperfusion affects clinical outcome in lung transplantation

Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia

Protective Effect of L-Arginine Preconditioning on Ischemia and Reperfusion Injury Associated with Rat Small Bowel Transplantation